Orion Corporation - Contract Pharma


Contract Service Directory

Orion Corporation





Company Headquarters

Orionintie 1
Espoo, 02100
Finland

Company Description

Orion is globally operating Finnish developer of pharmaceuticals. Orion provides contract manufacturing services for various formulation like potent drugs, semisolid hormones, oral cytotoxic, topicals, oral solids, nasals, liquids and small volume sterile injectable, packaging & seriliazation and API's as well. Our facilities comply with EMA, FDA, JP, ANVISA etc. quality standards.

Contract Service Directory

    Related Content

    • Breaking News | Drug Development | Trials & Filings
      SK Bio Gains FDA Approval for XCOPRI

      SK Bio Gains FDA Approval for XCOPRI

      Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval
      11.25.19

    • Biologics, Proteins, Vaccines | Biosimilars
      Biopharma Over 20 Years

      Biopharma Over 20 Years

      A look at the key trends that have impacted the biopharma industry over the years.
      K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19

    • Reader Showcase
      Thermo Scientific Introduces Handheld IonicX Analyzer

      Thermo Scientific Introduces Handheld IonicX Analyzer

      Designed to allow pharma and biopharma manufacturers to verify the identity of ionic salts in the warehouse in seconds
      11.15.19


    • The Role of Technology Within Regulatory Compliance in Bioanalysis

      The Role of Technology Within Regulatory Compliance in Bioanalysis

      Learn how current technology is playing a role in the regulatory process at PharmSci 360
      10.29.19

    • Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future

      Tuesday, November 5th, 1:30 PM - 2:30 PM   Keynote: FDA’s Continuous Manufacturing Journey: Past, Present and Future Location: 214 CD Manufacturing and Bioprocessing – Chemical…
      10.28.19

    • Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Injectables
      Pii to Manufacture FDA-Approved Hormone Therapy Injection Drug Product

      Pii to Manufacture FDA-Approved Hormone Therapy Injection Drug Product

      ANDA holder Sagent will sell, market and distribute the drug product in the U.S.
      09.23.19


    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • Cytotoxics and High Potency Manufacturing
      Highly Potent Expansions

      Highly Potent Expansions

      CDMOs see HPAPI demand rising
      S. Harachand, Contributing Editor 09.16.19

    • Regulatory Affairs
      Quality Metrics Feedback

      Quality Metrics Feedback

      A look at FDA’s Quality Metrics Initiative, a complicated issue for all of pharma stakeholders
      Gil Roth, President, Pharma & Biopharma Outsourcing Association 09.16.19


    • Breaking News | Clinical Trials | Industry News | Inspections | QA/QC
      FDA Extends CRADA with CluePoints

      FDA Extends CRADA with CluePoints

      Aims to further explore a data-driven approach to quality oversight in clinical trials
      09.11.19

    • Breaking News | Industry News | Inspections
      Bora Secures FDA Approval for CDMO Services

      Bora Secures FDA Approval for CDMO Services

      Reports successful inspection of Zhunan, Taiwan site
      09.03.19

    • cGMP Manufacture | Collaborations & Alliances
      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      NIIMBL, FDA to Advance Innovation in Bio Manufacturing

      CRADA enables FDA and NIIMBL to support investments in regulatory science research, and training needed to foster advanced manufacturing innovations
      08.01.19


    • Trials & Filings
      FDA Accepts RedHill Biopharma’s NDA for Talicia

      FDA Accepts RedHill Biopharma’s NDA for Talicia

      Commercial launch of H. pylori treatment is planned shortly following potential FDA approval
      07.16.19

    • 14	Bayer

      14 Bayer

      Headquarters: Leverkusen, Germany twitter.com/Bayer www.bayerpharma.com Headcount:  116,998 Year Established: 1971 Revenues:  $45,278   (+13%) Pharma Revenues:  $19,154   (-1%) Net Income:  $1,934&…
      07.15.19

    • Extractables and Leachables | Laboratory Testing
      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      The FDA Gets Stricter with E&L Oversight, Can the Industry Keep Up?

      Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
      Kristin Brooks, Contract Pharma 07.11.19

    • Trials & Filings
      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Sierra’s Momelotinib Granted FDA Fast Track Designation

      Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
      06.19.19

    • Risk-Based Monitoring

      Risk-Based Monitoring

      Leveraging intelligent analytics to realize the full value of RBx and compliance with ICH E6 (R2)
      Richard Davies, Vice President, Solution Expert, CluePoints 06.13.19

    • APIs
      Catching Up With Cambrex

      Catching Up With Cambrex

      Contract Pharma talks with Shawn Cavanagh about the recent acquisitions of Halo and Avista.
      Tim Wright, Editor, Contract Pharma 06.13.19

    • The Orphan Promise

      The Orphan Promise

      New policy on rare disease treatments likely soon
      S. Harachand, Contributing Editor 06.13.19